| New insights into atopic dermatitis DYM Leung, M Boguniewicz, MD Howell, I Nomura, QA Hamid The Journal of clinical investigation 113 (5), 651-657, 2004 | 2040 | 2004 |
| Cytokine modulation of atopic dermatitis filaggrin skin expression MD Howell, BE Kim, P Gao, AV Grant, M Boguniewicz, A DeBenedetto, ... Journal of Allergy and Clinical Immunology 124 (3), R7-R12, 2009 | 1397 | 2009 |
| Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes I Nomura, E Goleva, MD Howell, QA Hamid, PY Ong, CF Hall, MA Darst, ... The Journal of Immunology 171 (6), 3262-3269, 2003 | 948 | 2003 |
| Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 BE Kim, DYM Leung, M Boguniewicz, MD Howell Clinical immunology 126 (3), 332-337, 2008 | 581 | 2008 |
| IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitis J Bilsborough, DYM Leung, M Maurer, M Howell, M Boguniewcz, L Yao, ... Journal of Allergy and Clinical Immunology 117 (2), 418-425, 2006 | 443 | 2006 |
| Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus MD Howell, RL Gallo, M Boguniewicz, JF Jones, C Wong, JE Streib, ... Immunity 24 (3), 341-348, 2006 | 383 | 2006 |
| Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb A Wollenberg, MD Howell, E Guttman-Yassky, JI Silverberg, C Kell, ... Journal of Allergy and Clinical Immunology 143 (1), 135-141, 2019 | 374 | 2019 |
| Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum MD Howell, JF Jones, KO Kisich, JE Streib, RL Gallo, DYM Leung The Journal of Immunology 172 (3), 1763-1767, 2004 | 366 | 2004 |
| Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities MH Braff, MA Hawkins, AD Nardo, B Lopez-Garcia, MD Howell, C Wong, ... The Journal of Immunology 174 (7), 4271-4278, 2005 | 350 | 2005 |
| Cathelicidin deficiency predisposes to eczema herpeticum MD Howell, A Wollenberg, RL Gallo, M Flaig, JE Streib, C Wong, T Pavicic, ... Journal of Allergy and Clinical Immunology 117 (4), 836-841, 2006 | 349 | 2006 |
| T cell repertoire following autologous stem cell transplantation for multiple sclerosis PA Muraro, H Robins, S Malhotra, M Howell, D Phippard, C Desmarais, ... The Journal of clinical investigation 124 (3), 1168-1172, 2014 | 270 | 2014 |
| Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation MD Howell, HR Fairchild, BE Kim, L Bin, M Boguniewicz, JS Redzic, ... Journal of Investigative Dermatology 128 (9), 2248-2258, 2008 | 251 | 2008 |
| Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis MD Howell, N Novak, T Bieber, S Pastore, G Girolomoni, M Boguniewicz, ... Journal of investigative dermatology 125 (4), 738-745, 2005 | 247 | 2005 |
| Mechanism of HBD-3 deficiency in atopic dermatitis MD Howell, M Boguniewicz, S Pastore, N Novak, T Bieber, G Girolomoni, ... Clinical immunology 121 (3), 332-338, 2006 | 242 | 2006 |
| IL-4 and IL-13 negatively regulate TNF-α-and IFN-γ-induced β-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3 C Albanesi, HR Fairchild, S Madonna, C Scarponi, O De Pita, DYM Leung, ... The Journal of Immunology 179 (2), 984-992, 2007 | 236 | 2007 |
| Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial M Jagasia, MA Perales, MA Schroeder, H Ali, NN Shah, YB Chen, S Fazal, ... Blood, The Journal of the American Society of Hematology 135 (20), 1739-1749, 2020 | 223 | 2020 |
| TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier BE Kim, MD Howell, E Guttman, PM Gilleaudeau, IR Cardinale, ... Journal of Investigative Dermatology 131 (6), 1272-1279, 2011 | 220 | 2011 |
| IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation S Sehra, Y Yao, MD Howell, ET Nguyen, GS Kansas, DYM Leung, ... The Journal of Immunology 184 (6), 3186-3190, 2010 | 208 | 2010 |
| Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial D Rosmarin, AG Pandya, M Lebwohl, P Grimes, I Hamzavi, AB Gottlieb, ... The Lancet 396 (10244), 110-120, 2020 | 189 | 2020 |
| Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial MR Rigby, LA DiMeglio, MS Rendell, EI Felner, JM Dostou, SE Gitelman, ... The lancet Diabetes & endocrinology 1 (4), 284-294, 2013 | 183 | 2013 |
